Is IQQQ High Income ETF Good to Buy?
The Proshares NASDAQ-100 High Income ETF (IQQQ) is a covered…
Sell
35
JYNT Quote, Financials, Valuation and Earnings
Last price:
$10.01
Seasonality move
:
4.21%
Day range:
$9.60 - $10.82
52-week range:
$9.58 - $17.82
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
2.92x
P/B ratio:
8.48x
Volume:
82.7K
Avg. volume:
89.6K
1-year change:
-16.72%
Market cap:
$151.9M
Revenue:
$51.9M
EPS (TTM):
-$0.57
Analysts' Opinion
-
Consensus RatingThe Joint has received a consensus rating of Leans Bullish. The company's average rating is a Leans Bullish based on 2 Buy ratings, 2 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $16.38, The Joint has an estimated upside of 63.59% from its current price of $10.01.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $10.50 representing -- downside risk from its current price of $10.01.
Fair Value
-
According to the consensus of 4 analysts, The Joint has 63.59% upside to fair value with a price target of $16.38 per share.
JYNT vs. S&P 500
-
Over the past 5 trading days, The Joint has overperformed the S&P 500 by 1.53% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
The Joint does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
The Joint has grown year-over-year revenues for 3 quarters straight. In the most recent quarter The Joint reported revenues of -$38.3M.
Earnings Growth
-
The Joint earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter The Joint reported earnings per share of -$0.18.
Enterprise value:
126.9M
EV / Invested capital:
--
Price / LTM sales:
2.92x
EV / EBIT:
104.68x
EV / Revenue:
2.44x
PEG ratio (5yr expected):
--
EV / Free cash flow:
15.42x
Price / Operating cash flow:
18.42x
Enterprise value / EBITDA:
42.55x
Gross Profit (TTM):
$40.4M
Return On Assets:
-10.27%
Net Income Margin (TTM):
-16.44%
Return On Equity:
-37.87%
Return On Invested Capital:
-37.21%
Operating Margin:
4.57%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $101.3M | $47M | $51.9M | -$40.1M | -$38.3M | |
| Gross Profit | $92.1M | $36.5M | $40.4M | -$42.9M | -$41.4M | |
| Operating Income | $1.2M | $297.4K | -$1.7M | $1.1M | -$1.7M | |
| EBITDA | $7.9M | $8.9M | $3M | $2.8M | -$1.2M | |
| Diluted EPS | $0.03 | -$0.66 | -$0.57 | -$0.75 | -$0.18 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $25.3M | $26.9M | $17.6M | $44.3M | $72.2M | |
| Total Assets | $65.9M | $87.1M | $93.5M | $87.2M | $80.4M | |
| Current Liabilities | $18.5M | $21.4M | $23.2M | $33.6M | $49.4M | |
| Total Liabilities | $44.8M | $56.8M | $60.9M | $62.4M | $62.5M | |
| Total Equity | $21.1M | $30.3M | $32.6M | $24.8M | $17.9M | |
| Total Debt | $4.7M | $2M | $2M | $2M | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $8.2M | $14.7M | $9.4M | $3.4M | $4.1M | |
| Cash From Investing | -$17.9M | -$6.2M | -$631.5K | -$1.3M | -$104.3K | |
| Cash From Financing | $328.6K | $174.1K | -$2M | -$6.2K | -$24.9K | |
| Free Cash Flow | $2.3M | $9.7M | $8.2M | $2.2M | $3.8M | |
JYNT
Sector
Market Cap
$151.9M
$35M
Price % of 52-Week High
--
42.2%
Dividend Yield
0%
0%
Shareholder Yield
--
-0.81%
1-Year Price Total Return
-16.72%
-41.61%
Beta (5-Year)
1.454
0.742
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$10.27
200-day SMA
Sell
Level
$11.58
Bollinger Bands (100)
Sell
Level
10.44 - 11.9
Chaikin Money Flow
Buy
Level
2.7M
20-day SMA
Sell
Level
$11.40
Relative Strength Index (RSI14)
Sell
Level
34.14
ADX Line
Sell
Level
30.87
Williams %R
Buy
Level
-87.412
50-day SMA
Sell
Level
$11.36
MACD (12, 26)
Sell
Level
-0.43
25-day Aroon Oscillator
Sell
Level
-72
On Balance Volume
Neutral
Level
4.3M
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (1.9325)
Sell
CA Score
(Annual)
Level (-1.4429)
Buy
Beneish M-Score
(Annual)
Level (-4.2162)
Buy
Momentum Score
Level (8)
Sell
Ohlson Score
Level (3.2272)
Buy
Piotroski F Score
(Annual)
Level (8)
Buy
Quality Ratio Score
Level (6)
Buy
Fundamental Score
Level (6)
Revenue Forecast
Earnings per Share Forecast
Company Profile
The Joint Corp develops, owns, operates, supports, and manages chiropractic clinics through direct ownership, management arrangements, franchising, and the sales of regional developer rights throughout the United States. The doctors of chiropractic develop personalized treatment plans to relieve patients' pain and deliver ongoing preventative care. The Company has one operating business segment; The Franchise Operations segment which is comprised of the operating activities of the franchise business unit. The Franchise Operations segment derives revenue from customers by providing access to the Company’s franchise license, which represents symbolic intellectual property.
Stock Forecast FAQ
In the current month, JYNT has received 2 Buy ratings 2 Hold ratings, and 0 Sell ratings. The JYNT average analyst price target in the past 3 months is $16.38.
-
Where Will The Joint Stock Be In 1 Year?
According to analysts, the consensus estimate is that The Joint share price will rise to $16.38 per share over the next 12 months.
-
What Do Analysts Say About The Joint?
Analysts are divided on their view about The Joint share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that The Joint is a Sell and believe this share price will drop from its current level to $10.50.
-
What Is The Joint's Price Target?
The price target for The Joint over the next 1-year time period is forecast to be $16.38 according to 4 Wall Street analysts, 2 of them rate the stock a Buy, 0 rate the stock a Sell, and 2 analysts rate the stock a Hold.
-
Is JYNT A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for The Joint is a Leans Bullish. 2 of 4 analysts rate the stock a Leans Bullish at this time.
-
How Can I Buy Shares Of JYNT?
You can purchase shares of The Joint via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase The Joint shares.
-
What Is The The Joint Share Price Today?
The Joint was last trading at $10.01 per share. This represents the most recent stock quote for The Joint. Yesterday, The Joint closed at $10.01 per share.
-
How To Buy The Joint Stock Online?
In order to purchase The Joint stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Can Spotify Ever Become Consistently Profitable?
Spotify (NYSE:SPOT) owns more than 30% market share as the most…
Is American Express a Buy, Sell or Hold?
American Express (NYSE:AXP) holds a notable place in Warren Buffett’s…
Stock Ideas
Sell
50
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 32x
Sell
47
Is MSFT Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 31x
Sell
46
Is NVDA Stock a Buy?
Market Cap: $2.5T
P/E Ratio: 35x
Alerts
Sell
23
UNH alert for Apr 20
UnitedHealth Group [UNH] is down 22.4% over the past day.
Sell
32
MAN alert for Apr 20
ManpowerGroup [MAN] is down 19.07% over the past day.
Sell
24
GPN alert for Apr 20
Global Payments [GPN] is down 17.44% over the past day.
